Dr Reddy's Posts Q3 Net Profit On Strong India, US Sales

Despite challenging market conditions in most of its emerging markets and a 21 per cent sales drop in Russia, the company's net profit at Rs 579.2 crore for the quarter grew marginally compared to the year-ago quarter

Baba Ramdev's Patanjali Offers Atta Noodles 'Cheaper Than Rivals'

AstraZeneca Buys ZS Pharma For $2.7 Billion, Pips Actelion

Dr Reddy's Andhra, Telangana Plants Get FDA Warning

By CH Unnikrishnan Dr Reddy's Laboratories Ltd, India's second largest drug maker by revenue, said it received a warning letter from the US drug regulator over manufacturing facilities making pharmaceutical ingredients and oncology products in Andhra Pradesh and Telangana.

Ban On Maggi Noodles: Nestle Scores Win In Bombay High Court

Detergent, Frozen Fat Found In Mother Dairy Milk: FDA

FDA, WHO Tighten Scrutiny Of Indian Clinical Research Firms

Pharma Sector's Struggle To Tighten Standards Paves Way For M&A Deals

Wockhardt Hopes To Resolve FDA Ban On Two Plants In FY16

Ipca Slumps 14.5% After FDA Bans US Imports

Lupin Says FDA Raises Concerns Over Plant At Pithampur

US Bans Imports From Ipca Plant In Madhya Pradesh

Ranbaxy Net Loss Widens On Forex Loss

Sun Pharmaceutical Gets US Approval To Buy Ranbaxy

Europe Bars Imports From Ranbaxy MP Unit